CN106421629A - Oral medicine for treating bladder cancer - Google Patents

Oral medicine for treating bladder cancer Download PDF

Info

Publication number
CN106421629A
CN106421629A CN201510500729.XA CN201510500729A CN106421629A CN 106421629 A CN106421629 A CN 106421629A CN 201510500729 A CN201510500729 A CN 201510500729A CN 106421629 A CN106421629 A CN 106421629A
Authority
CN
China
Prior art keywords
medicine
bladder cancer
cold
effect
oral medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510500729.XA
Other languages
Chinese (zh)
Inventor
史宇林
史涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Hong Qianyao Chinese Medicine Research And Development Co Ltd
Original Assignee
Sichuan Hong Qianyao Chinese Medicine Research And Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Hong Qianyao Chinese Medicine Research And Development Co Ltd filed Critical Sichuan Hong Qianyao Chinese Medicine Research And Development Co Ltd
Priority to CN201510500729.XA priority Critical patent/CN106421629A/en
Publication of CN106421629A publication Critical patent/CN106421629A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to oral medicine for treating bladder cancer. The oral medicine comprises is 15-25g of kelp; 15-25g of seaweed; 15-25g of sea pumice; 15-25g of sea clams; 30-50g of raw oyster; 15-25g of earthworm; 10-20g of rhizoma sparganii; 10-20g of curcuma zedoary; 10-20g of rehmannia; 60-90g of hedyotis diffusa; 30-50g of scutellaria barbata; 10-20g of cluster mallow fruit; 30-50g of polygonum aviculare; 10-20g of lindera aggregate, and 10-20g of curcuma aromatica.

Description

The oral drugs for the treatment of bladder cancer
Technical background
The present invention relates to a kind of oral drugs treating bladder cancer.This drug on bladder cancer has specially good effect, to carcinoma of prostate, prostate Hypertrophy has specially good effect.
From the point of view of etiology and pathology, in theory of Chinese medical science, cancer is belonging to the disease category that traditional Chinese medical science abdominal mass gathers gall subcutaneous nodule.From the point of view of card It is belonging to the marquis of traditional Chinese medical science qi depression to blood stasis phlegm stagnating in meridian.The research to cancer for the Chinese medicine, had been described before more than 2,000 years, such as difficult warp, 55 difficulties are said:Disease have long-pending, have poly-, how not it.So;Long-pending person, cloudy gas.Poly- person, yang-energy.Therefore gloomily lie prostrate, sun is floating And move.The long-pending name of institute of gas is said long-pending, and the poly- name of institute of gas is said poly-.Therefore amassing person, the five internal organs are given birth to, poly- person, and six internal organs are become.Long-pending person's the moon gas, It has originated normal place, and its pain not from its portion, up and down all the time, locate thoroughly by left and right.Poly- person's yang-energy, it originates no basic, up and down Only no stayed, its migratory pain, meaning is poly-.Therefore to be not know accumulation.
56 difficulties are said:The five internal organs are long-pending, each famous, so:The long-pending name of liver says lump at the left hypochondrium, under left rib, such as inflammatory blepharoedema, and there is cephalopodium.The heart it Long-pending, name says fullness in the epigastrium especially referring to the abcess of the abdomen in ancient times, rises on neat, and big such as arm, up under the heart.Spleen is long-pending, and name says mass at the hypochondrium, in gastral cavilty, covers big such as disk.Lung sum name says breath Beautifully adorned, under right rib, cover big such as cup.The long-pending name of kidney says renal mass, sends out in few abdomen, up under the heart, if globefish shape, or up or down no when.Therefore after Generation five kinds of masses in the chest and abdomen for it.Property according to disease and form, are also divided into tumor and cancer two class it." Medical Treasures of the Golden Chamber " more specify that accumulation Difference, he says, accumulator is dirty, does not move eventually.The dirty abdominal mass of poly- person, disease appearing at regular intervals, toss about in bed pain and move." General Treatise on the Cause and Symptoms of Diseases " is pointed out again, With long-pending with abdominal mass is same with poly-.It is to form the main pathogenesis gathering that QI and blood of all recognizing ancient Chinese medicine doctor stagnates.All tumor invasions are many and feelings Will internal injury, improper diet, environmental pollution are relevant, cause the obstacle of the defeated cloth of QI and blood activity body fluid.Poly- liquid becomes expectorant, with the passing of time nucleation, Define the disease in qi depression to blood stasis phlegm stagnating in meridian curtain source.The meridians curtain source of the traditional Chinese medical science is not doctor trained in Western medicine organa parenchymatosum anatomically, but in The substantive tunnel of the burnt defeated cloth of QI-blood circulation body fluid in medical science upper, middle and lower three.In doctor trained in Western medicine, bladder cancer belongs to acute abdomen, the model of tumor Farmland, how using the method for the treatment of performed the operation with chemicotherapy.Cause cancer poison to flee, cancerous cell spreads, prognosis malas more.
Technical field
The purpose of the present invention is that development is a kind of can abandon the traditional operative therapy of doctor trained in Western medicine, and pre- anti-cancer poison is fled, the mouth of cancerous cell diffusion Medication thing.A kind of healing bladder cancer based on the inherent resistances against diseases of transfer and the oral drugs of carcinoma of prostate.
1. this medicine can be made into the forms such as powder, pill, tablet, capsule.
2. except having in addition to specially good effect to bladder cancer, to carcinoma of prostate, prostatic hyperplasia has specially good effect to this medicine.
3. this medicine is prohibited outside clothes to anemia of pregnant woman, no other side effect.
4. its manufacture method is simple.
5. overcome the deficiency of western medical treatment, easy to use, there is specially good effect to bladder cancer and carcinoma of prostate, no any damage, through inventor couple 10 many cases bladder cancer and 50 many cases prostatitis, prostate hyperplasia, the clinical practice of hypertrophy patient, do not find nonresponder and not so far Good reaction.It was verified that the bladder cancer patients to the initial stage, a course for the treatment of can be cured.The bladder cancer patients of mid-term, two courses for the treatment of can be controlled More.The bladder cancer patients in later stage, three courses for the treatment of can be cured.The medication natural law of each course for the treatment of is 40 to 60 days, and dosage is first wife Side's amount matter × 20 (pairs).The making and use method of the present invention is that some drugs are dried rear pulverization, by some drugs Concentrate, mix homogeneously to scale, be configured to pill, the matter weight of every pill is the 10g matter weight of crude drug in whole, daily clothes Medicine 3 times, 3 ball every time.Can be made into the forms such as tablet, capsule, daily and each course for the treatment of dose is identical with pill every time.
Content of the invention
The core of this medicine is, the raw material of this medicine composition by weight gram is:
Thallus Laminariae (Thallus Eckloniae) 15-25g Sargassum 15-25g Pumex 15-25g sea clam powder 15-25g Concha Ostreae 30-50g Pheretima 15-25g Rhizoma Sparganii 10-20g Rhizoma Curcumae 10-20g Radix Rehmanniae 10-20g Herba Hedyotidis Diffusae 60-90g Herba Scutellariae Barbatae 30-50g Semen Abutili 10-20g stores 30-50g Radix Linderae 10-20g Radix Curcumae 10-20g
The upper limit determined by exceeding in each component of said medicine will produce certain side effect, less than curative effect during its lower limit just Not notable.In the present invention, fully utilize the following effect in each drug component:
Thallus Laminariae (Thallus Eckloniae):Salty in the mouth, cold in nature, Return liver, stomach, kidney channel.Effect:Eliminating phlegm and softening indurated mass, clearing away heat and promoting diuresiss.The salty-cold matter of this product is slided, heat clearing away expectorant Softening the hard mass, with Sargassum, the efficacy of a drug is rich, for treating the key medicine of gall subcutaneous nodule for work(.
Sargassum:Salty in the mouth, cold in nature, Return liver, stomach, kidney channel.Effect:, heat clearing away expectorant, hard masses softening and resolving detumescence.For treatment goiter scrofula Key medicine.
Pumex:Salty in the mouth, cold in nature, return lung warp.Effect:Removing heat-phlegm, hard masses softening and resolving, treating stranguria and eliminating stone.This product cold energy heat clearing away, salty energy is soft Heavily fortified point, light weight floats, main lung heat clearing fire, expectorant heat, with old expectorant of dispelling cementing for its chief.
Sea clam powder:Bitter in the mouth, salty, cold in nature, attach to the lung and stomach meridians.Effect:Disappear transconversion into heat expectorant, hard masses softening and resolving, and can inducing diuresis to remove edema relieving gastric hyperacidity to alleviate stomachache. This product tremble with fear can heat clearing away, bitter can drop-down, salty can softening the hard mass, main enter lung meridian, therefore can clearing away lung-heat and change thick expectorant.
Concha Ostreae:Salty in the mouth, puckery, cold nature, Return liver, gallbladder, kidney channel.Effect:This product salty with hard masses softening and resolving, therefore for treatment scrofula subcutaneous nodule Good merchantable brand.
Pheretima:Salty in the mouth, cold in nature, Return liver, lung, bladder warp.Effect:Endogenous wind stopping disappears heat, dredging collateral, relieving asthma, sharp expectorant.This product salty-cold and under OK, property walk to alter and the meridian dredging thus use it.
Rhizoma Sparganii:Bitter in the mouth, property is pungent, Return liver, stomach.Effect:Dispelling the stagnated QI promoting the circulation of blood, Xiao Ji Zhi Tong.This product toil, drop-down, enter liver spleen two warp, Enter blood system to disappear with removing blood stasis dissipating blood stasis, enter edema caused by disorder of QI with gas consumption product pain relieving again, the depressed abdominal mass of the blood stasis that disappears is gathered, amenorrhea becomes silted up and hinders, its softening the hard mass It is quite strong that eliminating stagnation eliminates hard long-pending effect.
Rhizoma Curcumae:Bitter in the mouth, property pungent-warm, return liver warp.Effect:Circulation of qi promoting removing blood stasis, Xiao Ji Zhi Tong.The pungent scattered hardship of this product lets out warm logical, enter liver spleen two warp, Act on Rhizoma Sparganii similar, be all removing blood stasis dissipating blood stasis and disappear, the product of gas consumption product pain relieving, the work(Rhizoma Curcumae of right circulation of qi promoting is excellent, the power Rhizoma Sparganii of removing blood stasis For victory, two medicine composition mutual reinforcements between are use.Treatment abdominal mass accumulates coordinative role.
Radix Rehmanniae:Sweet in the mouth, bitter, cold in nature, GUIXIN, liver and kidney channel.Effect:The liver-cold matter of this product is moistened, clearing up internal heat by using drugs of bitter in taste and cold in nature, main enter the heart, liver, kidney Warp, is clearing away heat and cooling blood, the principal agent of YIN nourishing and the production of body fluid promoting, therefore yin nourishing is dispelled, pain is used.
Herba Hedyotidis Diffusae:Mildly bitter flavor, sweet, cold in nature, enter stomach, large intestine, small intestine meridian.Effect:Heat-clearing and toxic substances removing, dampness removing is treating stranguria, and this product has relatively Strong heat-clearing and toxic substances removing antineoplastic action.
Herba Scutellariae Barbatae:Acrid in the mouth, bitter, cold in nature, return lung, liver and kidney channel.Effect:Heat-clearing and toxic substances removing, blood stasis dispelling diuresis, detumescence.This product and Agkistrodon SHECAO can resist all tumors with use, can solve all cancer poison.
Semen Abutili:Sweet in the mouth, cold in nature, return large intestine, small intestine meridian.Effect:Inducing diuresis for treating stranguria syndrome, stimulating milk secretion, laxation.The sweet cold sliding profit of this product, slides with logical Key row is stagnant.The heat clearing away of cold energy, therefore have the work(of the treating stranguria pain relieving of clearing away heat and promoting diuresis.
Store:Sweet in the mouth, cold nature, return bladder warp.Effect:Clearing away heat and promoting diuresis, treating stranguria parasite killing.This product bitter cold settles descending work(and specially clears up Bladder damp and hot, have the work(of inducing diuresis for treating stranguria syndrome pain relieving.
The Radix Linderae:Acrid in the mouth, warm in nature, return lung, spleen, kidney, bladder warp.Effect:Promoting the circulation of QI to relieve pain, warming kidney for dispelling cold.This product pungent-warm perfume (or spice) is altered, on Walk lung spleen, assign kidney and declare smooth mechanism of qi, pleasant dispersing cold for relieving pain with bladder, warming kidney for dispelling cold, except the cold air of bladder.
Radix Curcumae:Acrid in the mouth, bitter, cold in nature, GUIXIN, lung, liver, gallbladder meridian.Effect:Promoting blood circulation to remove blood stasis, promoting QI circulation for relieving depression, clear away heart-fire removing heat from blood, and function of gallbladder promoting moves back Yellow.This product purging with bitter and cold drugs, pungent can walk to alter, that is, enter blood system and enter edema caused by disorder of QI, blood-activating and qi-promoting again, have the effect of dissipation congestion, happy mechanism of qi.Therefore There is the title of the gas medicine in blood system, the kind multiple diseases controlled caused by QI and blood retardance.
The present invention is to carry out compatibility by theory of Chinese medical science in a word, and its total effect is heat clearing away expectorant, removing toxic substances, blood-breaking, hard masses softening and resolving, Except amassing, inducing diuresis for treating stranguria syndrome reaches the purpose curing bladder cancer and carcinoma of prostate.
Feature of the present invention is:
This medicine can be made into the forms such as powder, pill, tablet, capsule.
Under be classified as embodiments of the invention:
Title Example 1 Example 2 Example 3 Example 4 Example 5
Thallus Laminariae (Thallus Eckloniae) 15g 18g 20g 22g 25g
Sargassum 15g 18g 20g 22g 25g
Pumex 15g 18g 20g 22g 25g
Sea clam powder 15g 18g 20g 22g 25g
Concha Ostreae 30g 36g 40g 45g 50g
Pheretima 15g 18g 20g 22g 25g
Rhizoma Sparganii 10g 12g 15g 18g 20g
Rhizoma Curcumae 10g 12g 15g 18g 20g
Radix Rehmanniae 10g 12g 15g 18g 20g
Herba Hedyotidis Diffusae 60g 72g 75g 85g 90g
Herba Scutellariae Barbatae 30g 36g 40g 45g 50g
Semen Abutili 10g 12g 15g 18g 20g
The Radix Linderae 10g 12g 15g 18g 20g
Store 30g 36g 40g 45g 50g
Radix Curcumae 10g 12g 15g 18g 20g
Several specific cases are described below:
1. Chengdu Longquanyi District store clerk is in phoenix show, female, 44 years old, and urine massive hemorrhage of going to toilet is sent to after being found by its colleague Chengdu the People's Hospital of province, is diagnosed as malignant tumor, bladder cancer through hospital, and color ultrasound is examined as 2.5 × 1.8 centimeters it is proposed that staying institute Operative treatment, treats because being afraid of that operation comes here, I uses 40 days course of therapy of medicine, the curative effect of the worried medicine of this patient, 16 Tian Houyouqu army hospitals of taking medicine check, carcinoma reduces only 0.8 centimeter, and confidence increases.Continue to take this medicine, a treatment Check to People's Hospital, Sichuan Prov. after journey again, make a definite diagnosis carcinoma and only have needle point size, continue to take half course for the treatment of recovery from illness of this medicine.
2. Zitong County Green Dragon township peasant Zhao so-and-so, man, 66 years old, solution urine was difficult, and in hospital of local township, county hospital is invalid, It is diagnosed as prostatic hyperplasia through county hospital, loose, doubtful carcinoma of prostate.Operative treatment is advised by school, because patient fears operation, Carry out here treatment, on inspection, pulse-taking be retarded pulse float, big, kidney deficiency is powerless, damp and hot gather in bladder, patient's private prosecution solution urine is tired Difficulty, with a small amount of hematuria.I is treated with this medicine former side decoction, 1 pair of medication, and patient's solution urine has been alleviated before relatively taking medicine, No hematuria.Patient continue medication 7 pairs when, no any clinical symptoms, for consolidating curative effect, patient takes medicine 2 pairs again, altogether take medicine 10 Pay and reach recovery from illness.
3. Zitong County retired employees Deng, man, 68 years old, it is diagnosed as prostatic hyperplasia in Zitong county people's hospital, handss are advised by school Art is treated.Because being afraid of operation, introduce here treatment through others, pulse condition is little late, floating, big on inspection, and kidney deficiency is powerless, empty Hot polymerization is in bladder.Patient takes 5 pairs of basis side with decoction, reaches recovery from illness, does not recur so far.
4. Zitong County peasant Feng so-and-so, man, 70 years old.Urinary obstruction, seeks medical advice no obvious curative effects in many places, through Zitong county people's hospital It is diagnosed as prostatic hyperplasia, inflammation is serious.Urethral catheterization is feared in patient's private prosecution.Carry out here treatment upon somebody's introduction, check arteries and veins through here As for:Left retarded pulse is small and weak, right floating and large pulse late, and kidney deficiency excess-heat gathers in bladder.Patient's urine is difficult to resolve, and is on tenterhooks, uses maneuver Attack a vital point (Guanyuan acupoint) urinate, urinate within 1 minute, urinated within 3 minutes.This medicine is taken with decoction by prescription basis side afterwards, and 1 pair little Just unobstructed, patient continues medication 10 days, totally 5 pairs, reaches recovery from illness.So far do not recur.

Claims (1)

1. treatment bladder cancer oral drugs it is characterized in that:This medicine is made up of agents raw material:
Thallus Laminariae (Thallus Eckloniae) 15-25g Sargassum 15-25g Pumex 15-25g sea clam powder 15-25g Concha Ostreae 30-50g Pheretima 15-25g Rhizoma Sparganii 10-20g Rhizoma Curcumae 10-20g Radix Rehmanniae 10-20g Herba Hedyotidis Diffusae 60-90g Herba Scutellariae Barbatae 30-50g Semen Abutili 10-20g stores 30-50g Radix Linderae 10-20g Radix Curcumae 10-20g.
CN201510500729.XA 2015-08-07 2015-08-07 Oral medicine for treating bladder cancer Pending CN106421629A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510500729.XA CN106421629A (en) 2015-08-07 2015-08-07 Oral medicine for treating bladder cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510500729.XA CN106421629A (en) 2015-08-07 2015-08-07 Oral medicine for treating bladder cancer

Publications (1)

Publication Number Publication Date
CN106421629A true CN106421629A (en) 2017-02-22

Family

ID=58093662

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510500729.XA Pending CN106421629A (en) 2015-08-07 2015-08-07 Oral medicine for treating bladder cancer

Country Status (1)

Country Link
CN (1) CN106421629A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101269187A (en) * 2008-05-08 2008-09-24 北京天科仁祥医药科技有限公司 Medicament composition for treating bladder cancer and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101269187A (en) * 2008-05-08 2008-09-24 北京天科仁祥医药科技有限公司 Medicament composition for treating bladder cancer and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
上海中医学院附属龙华医院肿瘤组: "中医扶正法在肿瘤治疗中的应用", 《新医药学杂志》 *
周滢等: "邓中甲治疗肿瘤的药对配伍", 《中国实验方剂学杂志》 *

Similar Documents

Publication Publication Date Title
CN102688420B (en) Traditional Chinese medicine decoction for treating psoriasis
CN104258289A (en) Traditional Chinese medicine for treating enteritis
CN102716383A (en) Traditional Chinese medicine composition for treating Crohn's disease
CN104189783A (en) Traditional Chinese medicine for treating oral ulcer
CN101607011B (en) Traditional Chinese medicine for treating cholecystitis post-operative complacation
CN103656461B (en) A kind of Chinese medicine pill and preparation method for the treatment of gastric cancer
CN102861296B (en) Pill inducing diuresis and reducing edema for treating gonarthromeningitis
CN104825944A (en) Drug for treating blood-heat psoriasis and preparation method thereof
CN103800842A (en) Traditional Chinese medicine composition for treating carcinoma of urinary bladder
CN103520670A (en) Traditional Chinese medicine composition for treating neonatal jaundice
CN102671070A (en) Traditional Chinese medicine composition for treating cancers or tumors
CN102614471A (en) Traditional Chinese medicine for treating breast carcinoma
CN104491447A (en) Compound medicine for treating gastrointestinal tract tumors
CN104306929A (en) Traditional Chinese medicine formula for treating severe acute pancreatitis and preparation method of traditional Chinese medicine formula
CN1583141A (en) Chinese medicine for cancer
CN102861292B (en) Medicament for treating esophageal cancer and preparation method thereof
CN102205067B (en) Traditional Chinese medicine composition for treating chronic urticaria
CN104013761A (en) Traditional Chinese medicine irrigating solution for treating ascaris intestinal obstruction
CN106421629A (en) Oral medicine for treating bladder cancer
CN102657727B (en) Medicine for treating colonitis and preparation method thereof
CN100534477C (en) Internal-applied traditional Chinese medicine decoction for treating nasopharyngeal cancer
CN106377743A (en) Traditional Chinese medicine composition for treating angioneurotic headache
CN106344838A (en) Chinese medicinal composition for treating oral ulcer
CN106581572A (en) Oral medicine for treating breast cancer
CN105106818A (en) Traditional Chinese medicine decoction for treating radiation proctitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170222

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170222